SCHEMBL6150149

SCHEMBL6150149

Nc1ccc(F)cc1[C]=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
KEAP1 Q14145 1/20 0.45
HDAC1 Q13547 3/20 0.34
GRM5 P41594 1/20 0.33
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
BACE1 P56817 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
FADS1 O60427 1/20 0.32
CCNE2 O96020 1/20 0.32
CCNE1 P24864 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9327450 0.82 ALDH1A1 (0.44) ALDH1A1KEAP1HDAC1GAAHTT
SCHEMBL28967099 0.81 ALDH1A1 (0.54) ALDH1A1KEAP1HDAC1GRM5GAA
SCHEMBL22134762 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1HDAC1GRM5GAA
SCHEMBL30262619 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1GAAHTT
SCHEMBL30182222 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1HDAC1GRM5GAA
SCHEMBL168901 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1GAAHTT
SCHEMBL7339958 0.76 ALDH1A1 (0.40) ALDH1A1GFER
SCHEMBL95486 0.76 CES2 (0.43) ALDH1A1GRM5CA6CA5ACA9
SCHEMBL8321394 0.73 TDP1 (0.52) ALDH1A1HTTCA1L3MBTL1
SCHEMBL3729165 0.73 TRPA1 (0.35) KEAP1HTTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1494700-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS Cytovia, Inc. (US) 2005-01-12 EP claimed
WO-2004002401-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS CYTOVIA, INC. (US) 2004-01-08 WO claimed
CN-108699241-A Polyalkyleneimino polymers with polyester groups 巴斯夫欧洲公司 2018-10-23 CN disclosed
EP-1494700-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS Cytovia, Inc. (US) 2005-01-12 EP disclosed
WO-2004002401-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS CYTOVIA, INC. (US) 2004-01-08 WO disclosed